Clinical trial

Effect of Sildenafil on Diffusion Capacity in Patients With PH and Parenchymal Lung Disease

NCT01948518

Study summary

ClinicalTrials.gov

Effect of Sildenafil on Diffusion Capacity in Patients With PH and Parenchymal Lung Disease

Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Oral sildenafil 20 mg Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2009-06-01

PhaseNA

Conditions

Diffuse Parenchymal Lung Diseaseunresolved

Pulmonary Hypertensionverified · MONDO: pulmonary hypertension

Interventions

Oral sildenafil 20 mgDRUG

Sponsors & collaborators

The Cleveland Cliniclead sponsor

Mapped research locations

ClevelandOhio, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01948518 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.